1. Metformin ameliorates scleroderma via inhibiting Th17 cells and reducing mTOR-STAT3 signaling in skin fibroblasts
   Jeonghyeon Moon et al, 2021, Journal of Translational Medicine CrossRef
2. Metformin attenuates multiple myeloma cell proliferation and encourages apoptosis by suppressing METTL3-mediated m6A methylation of THRAP3, RBM25, and USP4
   Cong-Jie Chen et al, 2023, Cell Cycle CrossRef
3. Vactosertib, TGF-β receptor I inhibitor, augments the sensitization of the anti-cancer activity of gemcitabine in pancreatic cancer
   Ji Eun Lee et al, 2023, Biomedicine & Pharmacotherapy CrossRef
4. LDLRAD2 promotes pancreatic cancer progression through Akt/mTOR signaling pathway
   Junhe Li et al, 2021, Medical Oncology CrossRef
5. Vitamin E in Chronic Myeloid Leukemia (CML) Prevention
   Lyudmyla Shvachko et al, 2021, Vitamin E in Health and Disease - Interactions, Diseases and Health Aspects CrossRef
6. Metformin Attenuates Silica-Induced Pulmonary Fibrosis by Activating Autophagy via the AMPK-mTOR Signaling Pathway
   Shu-xian Li et al, 2021, Frontiers in Pharmacology CrossRef
7. Transforming growth factor-beta (TGF-β) in prostate cancer: A dual function mediator?
   Sepideh Mirzaei et al, 2022, International Journal of Biological Macromolecules CrossRef
8. Drug repositioning in thyroid cancer treatment: the intriguing case of anti-diabetic drugs
   Alessia Greco et al, 2023, Frontiers in Pharmacology CrossRef
9. Type 2 Diabetes Mellitus Intersects With Pancreatic Cancer Diagnosis and Development
   Xiaoye Duan et al, 2021, Frontiers in Oncology CrossRef
10. Sinularin Exerts Anti-cancer Effects by Inducing Oxidative Stress-mediated Ferroptosis, Apoptosis, and Autophagy in Prostate Cancer Cells
    ZhengPing Wu et al, 2023, Anti-Cancer Agents in Medicinal Chemistry CrossRef
11. FZD7 accelerates hepatic metastases in pancreatic cancer by strengthening EMT and stemness associated with TGF-β/SMAD3 signaling
    Zhongbo Zhang et al, 2022, Molecular Medicine CrossRef
12. Acquired and intrinsic gemcitabine resistance in pancreatic cancer therapy: Environmental factors, molecular profile and drug/nanotherapeutic approaches
    Milad Ashrafizadeh et al, 2024, Environmental Research CrossRef